Jeremy Burton

Dr. Jeremy Burton

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2015 in Nature Reviews Urology
Verified
Journal Article
Closed access
SWSamantha A. Whiteside
Samantha A. Whiteside
HRHassan Razvi
Hassan Razvi
SDSumit Dave
Sumit Dave
GRGregor Reid
Gregor Reid
JBJeremy Burton
Jeremy Burton

6 July 2023 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
BRBertrand Routy
Bertrand Routy
JLJohn G. Lenehan
John G. Lenehan
WMWilson H. Miller
Wilson H. Miller
RJRahima Jamal
Rahima Jamal
MMMeriem Messaoudene
Meriem Messaoudene
SVSaman Maleki Vareki
Saman Maleki Vareki

15 May 2014 in Applied and Environmental Microbiology
Verified
Journal Article
Closed access
PDF file
CUCamilla Urbaniak
Camilla Urbaniak
JCJoanne Cummins
Joanne Cummins
MBMuriel Brackstone
Muriel Brackstone
JMJean M. Macklaim
Jean M. Macklaim
GGGregory B. Gloor
Gregory B. Gloor
GRGregor Reid
Gregor Reid
In recent years, a greater appreciation for the microbes inhabiting human body sites has emerged. In the female mammary gland, milk has been shown to contain bacterial species, ostensibly reaching the ducts from the skin. We decided to investigate whether there is a microbiome within the mammary tissue. Using 16S rRNA sequencing and culture, we analyzed breast tissue from 81 women with and without cancer in Canada and Ireland. A diverse population of bacteria was detected within tissue collected from sites all around the breast in women aged 18 to 90, not all of whom had a history of lactation. The principal phylum was Proteobacteria . The most abundant taxa in the Canadian samples were Bacillus (11.4%), Acinetobacter (10.0%), Enterobacteriaceae (8.3%), Pseudomonas (6.5%), Staphylococcus (6.5%), Propionibacterium (5.8%), Comamonadaceae (5.7%), Gammaproteobacteria (5.0%), and Prevotella (5.0%). In the Irish samples the most abundant taxa were Enterobacteriaceae (30.8%), Staphylococcus (12.7%), Listeria welshimeri (12.1%), Propionibacterium (10.1%), and Pseudomonas (5.3%). None of the subjects had signs or symptoms of infection, but the presence of viable bacteria was confirmed in some samples by culture. The extent to which these organisms play a role in health or disease remains to be determined.

15 May 2020 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
LCLaura Craven
Laura Craven
ARAdam Rahman
Adam Rahman
SPSeema Nair Parvathy
Seema Nair Parvathy
MBMelanie Beaton
Melanie Beaton
JSJustin Silverman
Justin Silverman
MSMichael Silverman
Michael Silverman
INTRODUCTION: Nonalcoholic fatty liver disease (NAFLD) is an obesity-related disorder that is rapidly increasing in incidence and is considered the hepatic manifestation of the metabolic syndrome. The gut microbiome plays a role in metabolism and maintaining gut barrier integrity. Studies have found differences in the microbiota between NAFLD and healthy patients and increased intestinal permeability in patients with NAFLD. Fecal microbiota transplantation (FMT) can be used to alter the gut microbiome. It was hypothesized that an FMT from a thin and healthy donor given to patients with NAFLD would improve insulin resistance (IR), hepatic proton density fat fraction (PDFF), and intestinal permeability. METHODS: Twenty-one patients with NAFLD were recruited and randomized in a ratio of 3:1 to either an allogenic (n = 15) or an autologous (n = 6) FMT delivered by using an endoscope to the distal duodenum. IR was calculated by HOMA-IR, hepatic PDFF was measured by MRI, and intestinal permeability was tested using the lactulose:mannitol urine test. Additional markers of metabolic syndrome and the gut microbiota were examined. Patient visits occurred at baseline, 2, 6 weeks, and 6 months post-FMT. RESULTS: There were no significant changes in HOMA-IR or hepatic PDFF in patients who received the allogenic or autologous FMT. Allogenic FMT patients with elevated small intestinal permeability (>0.025 lactulose:mannitol, n = 7) at baseline had a significant reduction 6 weeks after allogenic FMT. DISCUSSION: FMT did not improve IR as measured by HOMA-IR or hepatic PDFF but did have the potential to reduce small intestinal permeability in patients with NAFLD.

1 March 2002 in Microbes and Infection
Verified
Journal Article
Closed access
GRGregor Reid
Gregor Reid
JBJeremy Burton
Jeremy Burton

15 September 2012 in Applied and Environmental Microbiology
Verified
Journal Article
Closed access
PDF file
MMMarc Monachese
Marc Monachese
JBJeremy Burton
Jeremy Burton
GRGregor Reid
Gregor Reid
The food and water we consume are often contaminated with a range of chemicals and heavy metals, such as lead, cadmium, arsenic, chromium, and mercury, that are associated with numerous diseases. Although heavy-metal exposure and contamination are not a recent phenomenon, the concentration of metals and the exposure to populations remain major issues despite efforts at remediation. The ability to prevent and manage this problem is still a subject of much debate, with many technologies ineffective and others too expensive for practical large-scale use, especially for developing nations where major pollution occurs. This has led researchers to seek alternative solutions for decontaminating environmental sites and humans themselves. A number of environmental microorganisms have long been known for their ability to bind metals, but less well appreciated are human gastrointestinal bacteria. Species such asLactobacillus, present in the human mouth, gut, and vagina and in fermented foods, have the ability to bind and detoxify some of these substances. This review examines the current understanding of detoxication mechanisms of lactobacilli and how, in the future, humans and animals might benefit from these organisms in remediating environmental contamination of food.